chr17-6686332-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_177550.5(SLC13A5):c.1582A>G(p.Thr528Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000452 in 1,613,972 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_177550.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC13A5 | NM_177550.5 | c.1582A>G | p.Thr528Ala | missense_variant | Exon 12 of 12 | ENST00000433363.7 | NP_808218.1 | |
SLC13A5 | NM_001284509.2 | c.1531A>G | p.Thr511Ala | missense_variant | Exon 12 of 12 | NP_001271438.1 | ||
SLC13A5 | NM_001284510.2 | c.1453A>G | p.Thr485Ala | missense_variant | Exon 11 of 11 | NP_001271439.1 | ||
SLC13A5 | NM_001143838.3 | c.1444A>G | p.Thr482Ala | missense_variant | Exon 11 of 11 | NP_001137310.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152048Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000602 AC: 15AN: 249152Hom.: 0 AF XY: 0.0000371 AC XY: 5AN XY: 134870
GnomAD4 exome AF: 0.0000451 AC: 66AN: 1461806Hom.: 0 Cov.: 31 AF XY: 0.0000399 AC XY: 29AN XY: 727216
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152166Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74386
ClinVar
Submissions by phenotype
not provided Uncertain:2
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
SLC13A5: PM2, BP4 -
Developmental and epileptic encephalopathy, 25 Uncertain:2
- -
This sequence change replaces threonine, which is neutral and polar, with alanine, which is neutral and non-polar, at codon 528 of the SLC13A5 protein (p.Thr528Ala). This variant is present in population databases (rs569395560, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with SLC13A5-related conditions. ClinVar contains an entry for this variant (Variation ID: 452183). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt SLC13A5 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases Uncertain:1
The c.1582A>G (p.T528A) alteration is located in exon 12 (coding exon 12) of the SLC13A5 gene. This alteration results from a A to G substitution at nucleotide position 1582, causing the threonine (T) at amino acid position 528 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at